PharmaCyte Biotech, Inc.
Encapsulated live cell therapy platform for localized drug delivery, using microencapsulation of genetically modified cells to produce therapeutic molecules
- Sector
- Biotech
- Headquarters
- LAS VEGAS, NV
- Latest Form D
- $7M, Sep 2025
- Total capital
- $79.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $79.2M
- 4 Form D · last Sep 2025
- 14 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$7M
- Private capital raisedForm D · SEC · 3rd filing$70M
- Private capital raisedForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$1.1M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Carlos A. TrujilloExecutive Officer, DirectorNamed in SEC Form D filings
- Crabtree W. CrabtreeExecutive Officer, DirectorNamed in SEC Form D filings
- Gerald W CrabtreeExecutive Officer, DirectorNamed in SEC Form D filings
- Jonathan L. SchechterDirectorNamed in SEC Form D filings
- Joshua N. SilvermanExecutive Officer, DirectorNamed in SEC Form D filings
- Kenneth L. WaggonerExecutive Officer, DirectorNamed in SEC Form D filings
Show all 12 people
- Michael M. AbecassisDirectorNamed in SEC Form D filings
- Raymond CF TongDirectorNamed in SEC Form D filings
- Robert M. WeinsteinDirectorNamed in SEC Form D filings
- Thomas W LiquardDirectorNamed in SEC Form D filings
- Thomas C.K. YuenDirectorNamed in SEC Form D filings
- Walker R. WayneDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingEncapsulated Cells Producing Cytochrome P450 And Methods Of Use ThereofUSPTOApplication 17123941
- PendingEncapsulated Cells Producing Cytochrome P450 And Methods Of Use ThereofUSPTOApplication 15927528
- PendingEncapsulated Cells Producing Cytochrome P450 And Methods Of Use ThereofUSPTOApplication PCTUS2018023553
Show all 4 patent records
- Encapsulated Cells Producing Cytochrome P450 And Methods Of Use ThereofNov 11, 2021 · Application 17123941Pending
- Encapsulated Cells Producing Cytochrome P450 And Methods Of Use ThereofSep 27, 2018 · Application 15927528Pending
- Encapsulated Cells Producing Cytochrome P450 And Methods Of Use ThereofApplication PCTUS2018023553Pending
- Encapsulated Cells Producing Cytochrome P450 And Methods Of Use ThereofApplication 62474463Pending
Related companies, and why
- VBI Vaccines Inc/BCSimilar federal contract value in Biotech · null in contracts
- AUKERA, INC.Similar federal contract value in Biotech · null in contracts
- Vivodyne, Inc.Similar federal contract value in Biotech · null in contracts
- TREVENA INCSimilar federal contract value in Biotech · null in contracts
- LifeCyte Innovations, Inc.Similar federal contract value in Biotech · null in contracts
- Revalesio CorpSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .